Amino	B:C0002520
Acids	I:C0002520
Regulate	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
by	O
an	O
Obligate	O
Two	O
-	O
step	O
Mechanism	O
.	O

The	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
(	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
)	O
coordinates	O
cell	B:C0007595
growth	I:C0007595
with	O
its	O
nutritional	O
,	O
hormonal	O
,	O
energy	B:C0424589
,	O
and	O
stress	B:C0449430
status	O
.	O

Amino	B:C0002520
acids	I:C0002520
are	O
critical	O
regulators	O
of	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
that	O
permit	O
other	O
inputs	O
to	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
activity	O
.	O

However	O
,	O
the	O
roles	O
of	O
individual	O
amino	B:C0002520
acids	I:C0002520
and	O
their	O
interactions	O
in	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
activation	O
are	O
not	O
well	O
understood	O
.	O

Here	O
we	O
demonstrate	O
that	O
activation	O
of	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
by	O
amino	B:C0002520
acids	I:C0002520
includes	O
two	O
discrete	O
and	O
separable	O
steps	O
:	O
priming	O
and	O
activation	O
.	O

Sensitizing	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
activation	O
by	O
priming	O
amino	B:C0002520
acids	I:C0002520
is	O
a	O
prerequisite	O
for	O
subsequent	O
stimulation	B:C1292856
of	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
by	O
activating	O
amino	B:C0002520
acids	I:C0002520
.	O

Priming	O
is	O
achieved	O
by	O
a	O
group	O
of	O
amino	B:C0002520
acids	I:C0002520
that	O
includes	O
l-asparagine	B:C0003995
,	O
l-	B:C0017797
glutamine	I:C0017797
,	O
l-	B:C0040005
threonine	I:C0040005
,	O
l-arginine	B:C0003765
,	O
l-	B:C0017890
glycine	I:C0017890
,	O
l-	B:C0033382
proline	I:C0033382
,	O
l-	B:C0036720
serine	I:C0036720
,	O
l-	B:C0001898
alanine	I:C0001898
,	O
and	O
l-	B:C0061472
glutamic	I:C0061472
acid	I:C0061472
.	O

The	O
group	O
of	O
activating	O
amino	B:C0002520
acids	I:C0002520
is	O
dominated	O
by	O
l-leucine	B:C0023401
but	O
also	O
includes	O
l-methionine	B:C0025646
,	O
l-	B:C0022192
isoleucine	I:C0022192
,	O
and	O
l-valine	B:C0042285
.	O

l-	B:C0010654
Cysteine	I:C0010654
predominantly	O
inhibits	O
priming	O
but	O
not	O
the	O
activating	O
step	O
.	O

Priming	O
and	O
activating	O
steps	O
differ	O
in	O
their	O
requirements	O
for	O
amino	B:C0002520
acid	I:C0002520
concentration	O
and	O
duration	O
of	O
treatment	O
.	O

Priming	O
and	O
activating	O
amino	B:C0002520
acids	I:C0002520
use	O
mechanisms	O
that	O
are	O
distinct	O
both	O
from	O
each	O
other	O
and	O
from	O
growth	B:C0018284
factor	I:C0018284
signaling	B:C0037083
.	O

Neither	O
step	O
requires	O
intact	O
tuberous	B:C2247022
sclerosis	I:C2247022
complex	I:C2247022
of	I:C2247022
proteins	I:C2247022
to	O
activate	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
.	O

Concerted	O
action	O
of	O
priming	O
and	O
activating	O
amino	B:C0002520
acids	I:C0002520
is	O
required	O
to	O
localize	O
mechanistic	B:C3888046
target	I:C3888046
of	I:C3888046
rapamycin	I:C3888046
complex	I:C3888046
1	I:C3888046
to	O
lysosomes	B:C0024369
and	O
achieve	O
its	O
activation	O
.	O

